Company: NYXH
Filing Date: 2025-03-20
Form Type: F-3
Source: 0001104659-25-026217
Chunk: 17

Company: Nyxoah SA
Filing Date: 2025-03-20
Form: F-3
Chunk 17
---
 exercise of warrants for an aggregate consideration of approximately €51,706 (including share premium).

On March 6, 2024, we issued 8,650 ordinary shares pursuant to the exercise of warrants, for an aggregate consideration of €62,531 (including share premium).

On April 17, 2024, we issued 3,000 ordinary shares pursuant to the exercise of warrants, for an aggregate consideration of €16,260 (including share premium).

On May 28, 2024, we issued 5,374,755 ordinary shares in an underwritten public offering for an aggregate consideration of approximately $49.7 million (approximately €45.9 million at the then current exchange rates), before deducting underwriting discounts and commissions and estimated offering expenses.

On June 3, 2024, we issued 300,000 additional ordinary shares pursuant to the partial exercise of the greenshoe option in the underwritten public offering previously disclosed, for an aggregate consideration of approximately $2.8 million (approximately €2.6 million at the then current exchange rates), before deducting underwriting discounts and commissions and estimated offering expenses.

On June 24, 2024, we issued 12,625 ordinary shares pursuant to the exercise of warrants for an aggregate consideration of approximately €68,427 (including share premium).

On September 3, 2024, we issued 13,750 ordinary shares pursuant to the exercise of warrants for an aggregate consideration of €74,525 (including share premium).

On September 25, 2024, we issued 2,250 ordinary shares pursuant to the exercise of warrants for an aggregate consideration of €12,195 (including share premium).

On October 9, 2024, we issued 3 million ordinary shares pursuant to an at-the-market program for an aggregate consideration of approximately $27.0 million (approximately €24.6 million at the then current exchange rates).

On November 15, 2024, we issued 38,250 ordinary shares pursuant to the exercise of warrants for an aggregate consideration of €205,065 (including share premium).

#### Warrant Plans
We have established a number of warrant plans, under which we have granted warrants to our employees, officers, directors, consultants and advisors.

Each of the warrants issued on February 21, 2020, September 8, 2021, December 28, 2022, July 31, 2024 gives the holder thereof the right to subscribe to one of our ordinary shares